Supernus Reports Final Audited Fourth Quarter and Full Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Supernus Pharma (SUPN) Reports Q4 EPS of $0.04
April 13, 2022 4:13 PM EDTSupernus Pharma (NASDAQ: SUPN) reported Q4 EPS of $0.04, versus $0.57 reported last year. Revenue for the quarter came in at $159.1 million, versus $143.6 million reported last year.
GUIDANCE:
Supernus Pharma sees FY2022 revenue of $640-680 million.
For earnings history and earnings-related data on Supernus Pharma (SUPN) click here.
... More